Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 20 (1), 57-64
- https://doi.org/10.1016/s0168-8278(05)80467-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administrationHepatology, 1991
- Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot studyHepatology, 1991
- Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytesHepatology, 1990
- Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosisHepatology, 1990
- Ursodeoxycholic acid for primary sclerosing cholangitisJournal of Hepatology, 1990
- Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosisHepatology, 1989
- IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?The Lancet, 1987
- Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Primary Sclerosing CholangitisNew England Journal of Medicine, 1984
- Enzymic Analysis of Steroid HormonesPublished by Wiley ,1960